COMP <GO>
IRON vs ABBV // OPERATING MARGIN
Disc Medicine Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: IRON 4
— ABBV 10
▲ OPERATING MARGIN LEADER: ABBV
LAST: $80.84 (-2.41%) • MKT CAP: $3.68B
operating-margins
-22.90%
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
operating-margins
24.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRON VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IRON | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 70.20% | -29.20 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -27.50% | 29.00% | -56.50 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.93% | 3.47% | -8.40 | ABBV | /fcf-yield <GO> |
| Operating Margin ACTIVE | -22.90% | 24.60% | -47.50 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -20.60% | 6.90% | -27.50 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | 8.60% | +7.90 | IRON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.33 | +20.67 | IRON | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.40% | -0.80 | IRON | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.8 | 72.8 | -7.98 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 1.15 | -0.25 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.0x | 113.1x | -93.10 | IRON | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.68B | $513.86B | -$510.18B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IRON REV | ABBV REV | IRON GROSS % | ABBV GROSS % | IRON FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $61.16B | — | 70.2% | -$181.3M | $17.82B |
| FY 2024 | $0 | $56.33B | — | 70.0% | -$94.4M | $17.83B |
| FY 2023 | $0 | $54.32B | — | 44.0% | -$73.5M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRON // BETA 0.90
ABBV // BETA 1.15